1. Home
  2. VERV vs UVE Comparison

VERV vs UVE Comparison

Compare VERV & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • UVE
  • Stock Information
  • Founded
  • VERV 2018
  • UVE 1990
  • Country
  • VERV United States
  • UVE United States
  • Employees
  • VERV N/A
  • UVE N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • UVE Property-Casualty Insurers
  • Sector
  • VERV Health Care
  • UVE Finance
  • Exchange
  • VERV Nasdaq
  • UVE Nasdaq
  • Market Cap
  • VERV 475.0M
  • UVE 546.2M
  • IPO Year
  • VERV 2021
  • UVE 1992
  • Fundamental
  • Price
  • VERV $7.28
  • UVE $19.57
  • Analyst Decision
  • VERV Strong Buy
  • UVE Buy
  • Analyst Count
  • VERV 4
  • UVE 1
  • Target Price
  • VERV $25.75
  • UVE $25.00
  • AVG Volume (30 Days)
  • VERV 1.3M
  • UVE 121.7K
  • Earning Date
  • VERV 02-28-2025
  • UVE 02-25-2025
  • Dividend Yield
  • VERV N/A
  • UVE 3.93%
  • EPS Growth
  • VERV N/A
  • UVE 4.62
  • EPS
  • VERV N/A
  • UVE 2.48
  • Revenue
  • VERV $24,396,000.00
  • UVE $1,511,183,000.00
  • Revenue This Year
  • VERV $106.46
  • UVE N/A
  • Revenue Next Year
  • VERV N/A
  • UVE N/A
  • P/E Ratio
  • VERV N/A
  • UVE $7.89
  • Revenue Growth
  • VERV 219.91
  • UVE 12.23
  • 52 Week Low
  • VERV $4.31
  • UVE $16.50
  • 52 Week High
  • VERV $19.34
  • UVE $23.39
  • Technical
  • Relative Strength Index (RSI)
  • VERV 47.08
  • UVE 41.96
  • Support Level
  • VERV $7.44
  • UVE $19.72
  • Resistance Level
  • VERV $9.31
  • UVE $20.61
  • Average True Range (ATR)
  • VERV 0.67
  • UVE 0.40
  • MACD
  • VERV -0.12
  • UVE 0.03
  • Stochastic Oscillator
  • VERV 14.01
  • UVE 35.80

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

Share on Social Networks: